Jerome B. Zeldis, Director at Alliqua BioMedical, Inc. (ALQA), bought 400,000 shares at $0.50 ($200K) on 2017-02-27, disclosed to the SEC on 2017-03-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| NXGL | BUY | 2024-08-27 | $25K | — | Filing → |
| PTCT | SELL | 2024-05-24 | $765K | — | Filing → |
| NXGL | BUY | 2023-05-30 | $12K | — | Filing → |